The AHNS Emerging Technologies Award 2027 provides up to US$15,000 for one year of head and neck cancer research. The American Head and Neck Society (AHNS) offers this Presidential Award to support projects that use emerging technologies to improve early detection, risk prediction or assessment of treatment response.
Projects could use AI to assess risk from pathology slides, wearable devices to track symptoms after treatment, or spatial multi-omics to study why some tumours resist treatment. Applicants must explain how the technology fits into a translational or population-based clinical study and how they plan to validate it or use it in clinical practice.
Eligibility Criteria
- Applicants must reside in the United States or Canada and be AHNS members in good standing.
- Medical students, residents, fellows, graduate students, PhD researchers and faculty at the rank of associate professor or below may apply.
- Trainees are expected to have faculty support and mentorship.
- Projects must focus on head and neck cancer, use at least one emerging technology and include a translational or population-based clinical component.
- Previous AHNS or AAO-HNSF grant recipients may apply, but projects that have already secured private or federal funding for the same work are ineligible.
- The application requires support letters from the department chair, scientific adviser or mentor, and key project personnel.
Funding Details
- Maximum award: US$15,000.
- Duration: 12 months, with no renewal.
- Eligible costs: Research staff, consultants, software, equipment, laboratory supplies and project publication expenses.
Deadline
- Letter of intent: December 15, 2026, at 11:59 p.m. U.S. Eastern Time.
- Full application: January 15, 2027, at 11:59 p.m. U.S. Eastern Time.
Further Information
- Official 2027 award guidelines
- Apply through ProposalCentral
- Contact: loren@ahns.info